Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Evofem Biosciences
Evofem Biosciences
(EVFM)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Phexxi
Citric acid
,
Lactic acid
,
Potassium
2020-05-22
2023-2034
Urination disorders
,
Renal tubular acidosis
,
Dermatitis
,
Facial dermatoses
Solosec
Secnidazole
2017-09-15
2035
Bacterial vaginosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Citric acid
contraception
,
infections
,
chlamydia infections
Lactic acid
contraception
,
infections
,
chlamydia infections
Nonoxynol-9
contraception
Sodium chloride
infections
,
chlamydia infections
Sodium lactate
infections
,
chlamydia infections
Amphora
contraception
,
infections
,
chlamydia infections
Evo100
chlamydia infections
,
infections
,
gonorrhea
,
sexually transmitted diseases
Kcl
contraception
,
infections
,
chlamydia infections
Pbo
obesity
,
abdominal obesity
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use